Carna Biosciences, Inc. (4572.T)
JPY 280.0
(-1.41%)
JPY 280.0
(-1.41%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 28.4 Million JPY | -80.86% |
| 2022 | 148.4 Million JPY | -50.6% |
| 2021 | 300.39 Million JPY | 25.22% |
| 2020 | 239.88 Million JPY | -44.18% |
| 2019 | 429.78 Million JPY | -5.28% |
| 2018 | 453.75 Million JPY | 2.63% |
| 2017 | 442.12 Million JPY | -16.18% |
| 2016 | 527.45 Million JPY | 255.74% |
| 2015 | 148.27 Million JPY | 21.59% |
| 2014 | 121.94 Million JPY | 16.74% |
| 2013 | 104.46 Million JPY | 7.17% |
| 2012 | 97.47 Million JPY | -27.33% |
| 2011 | 134.14 Million JPY | 3.93% |
| 2010 | 129.06 Million JPY | 84.36% |
| 2009 | 70.01 Million JPY | 0.0% |
| 2008 | - JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 18.4 Million JPY | -21.36% |
| 2024 Q1 | 23.4 Million JPY | -17.6% |
| 2023 Q4 | 28.4 Million JPY | -51.38% |
| 2023 Q2 | 88.4 Million JPY | -25.33% |
| 2023 FY | 28.4 Million JPY | -80.86% |
| 2023 Q3 | 58.41 Million JPY | -33.93% |
| 2023 Q1 | 118.4 Million JPY | -20.21% |
| 2022 Q3 | 178.39 Million JPY | -21.2% |
| 2022 Q2 | 226.39 Million JPY | -11.7% |
| 2022 Q1 | 256.39 Million JPY | -14.65% |
| 2022 FY | 148.4 Million JPY | -50.6% |
| 2022 Q4 | 148.4 Million JPY | -16.81% |
| 2021 Q3 | 106.85 Million JPY | -31.45% |
| 2021 Q2 | 155.87 Million JPY | -18.34% |
| 2021 Q1 | 190.88 Million JPY | -20.43% |
| 2021 Q4 | 300.39 Million JPY | 181.12% |
| 2021 FY | 300.39 Million JPY | 25.22% |
| 2020 Q2 | 327.51 Million JPY | -10.54% |
| 2020 Q1 | 366.08 Million JPY | -14.82% |
| 2020 FY | 239.88 Million JPY | -44.18% |
| 2020 Q4 | 239.88 Million JPY | -12.73% |
| 2020 Q3 | 274.89 Million JPY | -16.07% |
| 2019 FY | 429.78 Million JPY | -5.28% |
| 2019 Q1 | 397.01 Million JPY | -12.51% |
| 2019 Q2 | 354.26 Million JPY | -10.77% |
| 2019 Q3 | 497.52 Million JPY | 40.44% |
| 2019 Q4 | 429.78 Million JPY | -13.62% |
| 2018 Q3 | 496.49 Million JPY | -10.59% |
| 2018 Q4 | 453.75 Million JPY | -8.61% |
| 2018 Q2 | 555.32 Million JPY | -9.14% |
| 2018 FY | 453.75 Million JPY | 2.63% |
| 2018 Q1 | 611.15 Million JPY | 38.23% |
| 2017 Q3 | 392.73 Million JPY | -11.21% |
| 2017 FY | 442.12 Million JPY | -16.18% |
| 2017 Q4 | 442.12 Million JPY | 12.57% |
| 2017 Q2 | 442.32 Million JPY | -7.44% |
| 2017 Q1 | 477.89 Million JPY | -9.4% |
| 2016 Q1 | 134.37 Million JPY | -9.37% |
| 2016 FY | 527.45 Million JPY | 255.74% |
| 2016 Q4 | 527.45 Million JPY | -6.32% |
| 2016 Q3 | 563.02 Million JPY | 31.98% |
| 2016 Q2 | 426.58 Million JPY | 217.46% |
| 2015 Q2 | 102.48 Million JPY | -8.67% |
| 2015 Q1 | 112.21 Million JPY | -7.98% |
| 2015 FY | 148.27 Million JPY | 21.59% |
| 2015 Q4 | 148.27 Million JPY | -8.57% |
| 2015 Q3 | 162.17 Million JPY | 58.24% |
| 2014 FY | 121.94 Million JPY | 16.74% |
| 2014 Q4 | 121.94 Million JPY | -7.39% |
| 2014 Q3 | 131.68 Million JPY | 52.36% |
| 2014 Q2 | 86.42 Million JPY | -9.45% |
| 2014 Q1 | 95.44 Million JPY | -8.63% |
| 2013 FY | 104.46 Million JPY | 7.17% |
| 2013 Q1 | 92.62 Million JPY | -4.98% |
| 2013 Q2 | 87.76 Million JPY | -5.24% |
| 2013 Q3 | 113.48 Million JPY | 29.3% |
| 2013 Q4 | 104.46 Million JPY | -7.95% |
| 2012 FY | 97.47 Million JPY | -27.33% |
| 2012 Q2 | 107.18 Million JPY | -7.47% |
| 2012 Q3 | 102.32 Million JPY | -4.53% |
| 2012 Q4 | 97.47 Million JPY | -4.74% |
| 2012 Q1 | 115.83 Million JPY | -13.65% |
| 2011 FY | 134.14 Million JPY | 3.93% |
| 2011 Q4 | 134.14 Million JPY | -11.43% |
| 2011 Q1 | 114.62 Million JPY | -11.19% |
| 2011 Q3 | 151.44 Million JPY | 51.18% |
| 2011 Q2 | 100.17 Million JPY | -12.61% |
| 2010 Q1 | 135.01 Million JPY | 92.85% |
| 2010 Q2 | 124.76 Million JPY | -7.59% |
| 2010 Q4 | 129.06 Million JPY | -10.07% |
| 2010 FY | 129.06 Million JPY | 84.36% |
| 2010 Q3 | 143.51 Million JPY | 15.03% |
| 2009 Q4 | 70.01 Million JPY | -2.77% |
| 2009 Q3 | 72 Million JPY | 0.0% |
| 2009 Q2 | - JPY | 0.0% |
| 2009 Q1 | - JPY | 0.0% |
| 2009 FY | 70.01 Million JPY | 0.0% |
| 2008 FY | - JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 767.03 Million JPY | 96.297% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 2 Billion JPY | 98.58% |
| Linical Co., Ltd. | 1.49 Billion JPY | 98.106% |
| Trans Genic Inc. | 1.32 Billion JPY | 97.86% |
| MEDINET Co., Ltd. | 781 Thousand JPY | -3536.62% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.34 Billion JPY | 98.79% |
| AnGes, Inc. | 214.94 Million JPY | 86.787% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | 73.419% |
| Nxera Pharma Co., Ltd. | 63.21 Billion JPY | 99.955% |
| Immuno-Biological Laboratories Co., Ltd. | 84.56 Million JPY | 66.412% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 97.439% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 875.59 Million JPY | 96.756% |
| RaQualia Pharma Inc. | 39.05 Million JPY | 27.268% |
| Chiome Bioscience Inc. | - JPY | -Infinity% |
| Kidswell Bio Corporation | 1.83 Billion JPY | 98.455% |
| PeptiDream Inc. | 19.63 Billion JPY | 99.855% |
| Oncolys BioPharma Inc. | 161.1 Million JPY | 82.37% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 397 Million JPY | 92.846% |
| Healios K.K. | 450 Million JPY | 93.688% |
| BrightPath Biotherapeutics Co., Ltd. | - JPY | -Infinity% |
| Kubota Pharmaceutical Holdings Co., Ltd. | - JPY | -Infinity% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 77.29 Million JPY | 63.253% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 773.29 Million JPY | 96.327% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 788 Million JPY | 96.396% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 491.35 Million JPY | 94.22% |
| StemCell Institute Inc. | 6.67 Million JPY | -325.434% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 143.75 Million JPY | 80.242% |